BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8326854)

  • 1. Detection and some properties of the sialyltransferase implicated in the sialylation of lipopolysaccharide of Neisseria gonorrhoeae.
    Mandrell RE; Smith H; Jarvis GA; Griffiss JM; Cole JA
    Microb Pathog; 1993 Apr; 14(4):307-13. PubMed ID: 8326854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate enhancement of sialylation of gonococcal lipopolysaccharide and of induction of serum resistance by CMP-NANA is not due to direct activation of the sialyltransferase: metabolic events are involved.
    Parsons NJ; Emond JP; Goldner M; Bramley J; Crooke H; Cole JA; Smith H
    Microb Pathog; 1996 Sep; 21(3):193-204. PubMed ID: 8878016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of metabolites by gonococci grown with lactate in a medium containing glucose: evidence for a surface location of the sialyltransferase.
    Gao L; Linden L; Parsons NJ; Cole JA; Smith H
    Microb Pathog; 2000 May; 28(5):257-66. PubMed ID: 10799276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate.
    McGee DJ; Rest RF
    Infect Immun; 1996 Nov; 64(11):4630-7. PubMed ID: 8890217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.
    Emond JP; Dublanchet A; Goldner M
    Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the lipopolysaccharide-specific sialyltransferase activity of gonococci by the growth state of the bacteria, but not by carbon source, catabolite repression or oxygen supply.
    Regan T; Watts A; Smith H; Cole J
    Antonie Van Leeuwenhoek; 1999 May; 75(4):369-79. PubMed ID: 10510725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.
    Frangipane JV; Rest RF
    Infect Immun; 1993 May; 61(5):1657-66. PubMed ID: 8478054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars.
    Parsons NJ; Constantinidou C; Cole JA; Smith H
    Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
    Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
    mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of sialyltransferase is not required for interaction of Neisseria gonorrhoeae with human epithelial cells and human neutrophils.
    McGee DJ; Chen GC; Rest RF
    Infect Immun; 1996 Oct; 64(10):4129-36. PubMed ID: 8926079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of a lipooligosaccharide-specific sialyltransferase in pathogenic and non-pathogenic Neisseria.
    Mandrell RE; Griffiss JM; Smith H; Cole JA
    Microb Pathog; 1993 Apr; 14(4):315-27. PubMed ID: 8326855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high Mr factor in human blood which confers serum resistance on gonococci: some properties and synergism with CMP-NANA.
    Constantinidou C; Beadle D; Zhou XH; Parsons NJ; Sammons CC; Cole JA; Smith H
    Microb Pathog; 1992 Jun; 12(6):421-32. PubMed ID: 1522797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic acid is the factor in blood cell extracts which enhances the ability of CMP-NANA to sialylate gonococcal lipopolysaccharide and induce serum resistance.
    Parsons NJ; Boons GJ; Ashton PR; Redfern PD; Quirk P; Gao Y; Constantinidou C; Patel J; Bramley J; Cole JA; Smith H
    Microb Pathog; 1996 Feb; 20(2):87-100. PubMed ID: 8722097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae strain F62: instability of transposon Tn1545 delta3 in gonococci and evidence that multiple genetic loci are essential for lipooligosaccharide sialylation.
    Crooke H; Griffiss JM; John CM; Lissenden S; Bramley J; Regan T; Smith H; Cole J
    Microb Pathog; 1998 Nov; 25(5):237-52. PubMed ID: 9878453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Neisseria lipooligosaccharide-specific alpha-2,3-sialyltransferase is a surface-exposed outer membrane protein.
    Shell DM; Chiles L; Judd RC; Seal S; Rest RF
    Infect Immun; 2002 Jul; 70(7):3744-51. PubMed ID: 12065517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
    Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA
    J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serum-sensitive, sialyltransferase-deficient mutant of Neisseria gonorrhoeae defective in conversion to serum resistance by CMP-NANA or blood cell extracts.
    Bramley J; Demarco de Hormaeche R; Constantinidou C; Nassif X; Parsons N; Jones P; Smith H; Cole J
    Microb Pathog; 1995 Mar; 18(3):187-95. PubMed ID: 7565013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'.
    Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H
    Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae.
    Gill MJ; McQuillen DP; van Putten JP; Wetzler LM; Bramley J; Crooke H; Parsons NJ; Cole JA; Smith H
    Infect Immun; 1996 Aug; 64(8):3374-8. PubMed ID: 8757878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.